pCMV-HA-hIFITM2 Citations (4)

Originally described in: Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.
Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, Lopez CB, Hang HC Nat Chem Biol. 2010 Aug;6(8):610-4. doi: 10.1038/nchembio.405. Epub 2010 Jul 4. PubMed Journal

---

Articles Citing pCMV-HA-hIFITM2

Articles
IFITM proteins inhibit the late step of feline foamy virus replication. Kim J, Shin CG. Anim Cells Syst (Seoul). 2020 Sep 15;24(5):282-288. doi: 10.1080/19768354.2020.1819413. PubMed
The Role of IFITM Proteins in Tick-Borne Encephalitis Virus Infection. Chmielewska AM, Gomez-Herranz M, Gach P, Nekulova M, Bagnucka MA, Lipinska AD, Rychlowski M, Hoffmann W, Krol E, Vojtesek B, Sloan RD, Bienkowska-Szewczyk K, Hupp T, Ball K. J Virol. 2022 Jan 12;96(1):e0113021. doi: 10.1128/JVI.01130-21. Epub 2021 Oct 6. PubMed
The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation. Shilagardi K, Spear ED, Abraham R, Griffin DE, Michaelis S. mBio. 2022 Oct 26;13(5):e0254322. doi: 10.1128/mbio.02543-22. Epub 2022 Oct 5. PubMed
TLR-mediated aggresome-like induced structures comprise antimicrobial peptides and attenuate intracellular bacterial survival. Bhatnagar A, Chopra U, Raja S, Das KD, Mahalingam S, Chakravortty D, Srinivasula SM. Mol Biol Cell. 2024 Mar 1;35(3):ar34. doi: 10.1091/mbc.E23-09-0347. Epub 2024 Jan 3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.